Transcripts Novartis AG Mexican S.E.

Stocks

End-of-day quote Mexican S.E. 25/09/2026			5-day change	1st Jan Change
2,572.00 ^MXN	+5.24%		+5.24%	+2.88%

09-30	Merck's experimental skin disease drug succeeds in mid-stage study	RE
09-30	Major drugmakers turn to China for licensing deals	RE

07-21	Novartis AG, Q2 2026 Earnings Call, Jul 21, 2026
04-28	Novartis AG, Q1 2026 Earnings Call, Apr 28, 2026
03-06	Novartis AG - Shareholder/Analyst Call
02-04	Novartis AG, Q4 2025 Earnings Call, Feb 04, 2026
01-12	Novartis AG Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 09:00 AM
12-01	Novartis AG - Special Call
11-22	Novartis AG - Shareholder/Analyst Call
11-21	Novartis AG - Shareholder/Analyst Call
30/10/25	Novartis AG - Special Call
28/10/25	Novartis AG, Q3 2025 Earnings Call, Oct 28, 2025
17/07/25	Novartis AG, Q2 2025 Earnings Call, Jul 17, 2025
29/04/25	Novartis AG, Q1 2025 Earnings Call, Apr 29, 2025
31/01/25	Novartis AG, Q4 2024 Earnings Call, Jan 31, 2025
14/01/25	Novartis AG Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-14-2025 08:15 AM
09/12/24	Novartis AG - Special Call
21/11/24	Novartis AG - Shareholder/Analyst Call
29/10/24	Novartis AG, Q3 2024 Earnings Call, Oct 29, 2024
28/10/24	Novartis AG - Shareholder/Analyst Call
18/07/24	Novartis AG, Q2 2024 Earnings Call, Jul 18, 2024
23/04/24	Novartis AG, Q1 2024 Earnings Call, Apr 23, 2024
05/03/24	Novartis AG - Shareholder/Analyst Call
06/02/24	MorphoSys AG, Novartis AG - M&A Call
31/01/24	Novartis AG, 2023 Earnings Call, Jan 31, 2024
08/01/24	Novartis AG Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 08:15 AM
28/11/23	Novartis AG - Special Call